Figures computed from official regulatory filings — .
Insufficient history for a statistical track record (fewer than 5 open-market buys).
This page republishes public regulatory disclosures.
| Company | Type | Value · USD | Signals | Details | |
|---|---|---|---|---|---|
BrightSpring Health Services, Inc.Listing on record | Sell | $253.9M | SEC | ||
BrightSpring Health Services, Inc.Listing on record | Sell | $1502.8T | Unusual size | SEC | |
RespireRx Pharmaceuticals Inc.Listing unverified | Sell | $991.6M | SEC | ||
Cencora, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Cencora, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Cencora, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Cencora, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Cencora, Inc.Listing on record | Sell | $50M | SEC | ||
Cencora, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Cencora, Inc.Listing on record | Sell | $50M | SEC | ||
Cencora, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Cencora, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Cencora, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Cencora, Inc.Listing on record | OtherD (derivative) | n/a (No price was disclosed in the filing) | SEC | ||
Option Care Health, Inc.Listing on record | Sell | $468.9M | SEC | ||
Cencora, Inc.Listing on record | Sell | $984.1M | SEC | ||
Cencora, Inc.Listing on record | Sell | $2B | SEC | ||
Cencora, Inc.Listing on record | Sell | $900M | SEC | ||
Cencora, Inc.Listing on record | OtherD (derivative) | n/a (Non-cash transaction: the filing states a price of zero (award, gift, exercise)) | SEC | ||
Cencora, Inc.Listing on record | Other | $1.2B | SEC |